Market Overview:
The global facial paralysis treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of facial paralysis, rising awareness about the available treatments, and technological advancements in the field of facial paralysis treatment. The global facial paralysis treatment market can be segmented on the basis of type, application, and region. On the basis of type, the market can be divided into medications and physical therapy. The medications segment is further sub-segmented into drugs and surgery. Physical therapy includes therapies such as electrical stimulation therapy (EST), transcranial magnetic stimulation (TMS), biofeedback training, and others). On the basis of application, hospitals account for a major share in terms of revenue followed by clinics research centers Others include home care settings and ambulatory surgical centers).
Product Definition:
Facial paralysis is a condition that results in an inability to move one or more muscles on one side of the face. Treatment may involve exercises to help improve muscle strength and movement, electrical stimulation, or surgery. It is important to seek treatment for facial paralysis as soon as possible to help preserve function and improve quality of life.
Medications:
Medications, it's usage and growth factor in facial paralysis treatment market is a study of the pharmaceutical industry with respect to drugs for facial nerve (paralysis) impairment. The medications are used in the form of injections, tablets or liquids for providing relief from pain caused by damaged nerves.
Physical Therapy:
Physical therapy is a rehabilitation service that helps patients recover from physical injuries and disabilities through the application of physical force. It aims to restore movement and other functional abilities impaired by neurological problems, orthopedic conditions, or muscle sprains. Physical therapy can be used for treatment of various facial paralysis disorders such as stroke-induced facial paralysis or Bell's Palsy.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and other medical facilities, research centers and others. Hospitals held the largest share of the global market in 2017 owing to availability of advanced healthcare facilities along with a large number of Facial Nerve Disorders patients that require treatment.
The clinics and other medical facilities segment is expected to grow at a lucrative rate during the forecast period due to increasing awareness about FND treatment among various providers across countries such as Germany, U.K., China Japan etc. Furthermore, rising cases related to Bell's Palsy are anticipated to boost demand for facial paralysis treatments over next few years. According these treatments are required in majority of cases Bell¢â‚¬â„¢s Palsy (temporary facial paralysis) or permanent face Ž© numbness & tingling sensation (permanent faciaballism).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the availability of technologically advanced devices, high awareness levels pertaining to treatment options, and presence of well-established healthcare facilities in this region. Moreover, increasing cases of facial paralysis due to various reasons are propelling the demand for treatments in this region. According to a study published by National Institute of Neurological Disorders & Strokes (NINDS), between January 1 st , 2000 and December 31 st , 2016 there were 647 cases reported from 46 states across U.S., which indicate a significant increase over previous years (data on file).
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising disposable income leading towards increased adoption of Facial Nerve Stimulation devices among patients seeking treatment at private hospitals as well as non-profit organizations such as FNC Foundation and Action Medical Research Centre India amongst others).
Growth Factors:
- Increasing incidence of facial paralysis
- Growing awareness about facial paralysis treatment options
- Rising demand for minimally invasive procedures
- Technological advancements in facial paralysis treatment procedures
- Growing number of surgical and non-surgical treatment options
Scope Of The Report
Report Attributes
Report Details
Report Title
Facial Paralysis Treatment Market Research Report
By Type
Medications, Physical Therapy
By Application
Hospitals, Clinics, Research Centers, Others
By Companies
Boston Scientific, Novartis, BioControl Medical, Cerebomed, Cyberonics, Astellas Pharma, Sucampo Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Facial Paralysis Treatment Market Report Segments:
The global Facial Paralysis Treatment market is segmented on the basis of:
Types
Medications, Physical Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Research Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Novartis
- BioControl Medical
- Cerebomed
- Cyberonics
- Astellas Pharma
- Sucampo Pharmaceuticals
Highlights of The Facial Paralysis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medications
- Physical Therapy
- By Application:
- Hospitals
- Clinics
- Research Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Facial Paralysis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Facial paralysis treatment is a medical procedure that helps to restore movement in the face. This can be done by restoring function to the muscles and nerves that control facial expression.
Some of the major companies in the facial paralysis treatment market are Boston Scientific, Novartis, BioControl Medical, Cerebomed, Cyberonics, Astellas Pharma, Sucampo Pharmaceuticals.
The facial paralysis treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Facial Paralysis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Facial Paralysis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Facial Paralysis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Facial Paralysis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Facial Paralysis Treatment Market Size & Forecast, 2018-2028
4.5.1 Facial Paralysis Treatment Market Size and Y-o-Y Growth
4.5.2 Facial Paralysis Treatment Market Absolute $ Opportunity
Chapter 5 Global Facial Paralysis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Facial Paralysis Treatment Market Size Forecast by Type
5.2.1 Medications
5.2.2 Physical Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Facial Paralysis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Facial Paralysis Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Research Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Facial Paralysis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Facial Paralysis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Facial Paralysis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Facial Paralysis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Facial Paralysis Treatment Market Size Forecast by Type
9.6.1 Medications
9.6.2 Physical Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Facial Paralysis Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Research Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Facial Paralysis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Facial Paralysis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Facial Paralysis Treatment Market Size Forecast by Type
10.6.1 Medications
10.6.2 Physical Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Facial Paralysis Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Research Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Facial Paralysis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Facial Paralysis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Facial Paralysis Treatment Market Size Forecast by Type
11.6.1 Medications
11.6.2 Physical Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Facial Paralysis Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Research Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Facial Paralysis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Facial Paralysis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Facial Paralysis Treatment Market Size Forecast by Type
12.6.1 Medications
12.6.2 Physical Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Facial Paralysis Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Research Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Facial Paralysis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Facial Paralysis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Facial Paralysis Treatment Market Size Forecast by Type
13.6.1 Medications
13.6.2 Physical Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Facial Paralysis Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Research Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Facial Paralysis Treatment Market: Competitive Dashboard
14.2 Global Facial Paralysis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Novartis
14.3.3 BioControl Medical
14.3.4 Cerebomed
14.3.5 Cyberonics
14.3.6 Astellas Pharma
14.3.7 Sucampo Pharmaceuticals
